These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 30356362

  • 1. Monitoring Anti-NS1 Antibodies in West Nile Virus-Infected and Vaccinated Horses.
    Rebollo B, Sarraseca J, Lecollinet S, Abouchoaib N, Alonso J, García-Bocanegra I, Sanz AJ, Venteo Á, Jiménez-Clavero MA.
    Biomed Res Int; 2018; 2018():8309816. PubMed ID: 30356362
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
    Chaintoutis SC, Diakakis N, Papanastassopoulou M, Banos G, Dovas CI.
    Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384
    [Abstract] [Full Text] [Related]

  • 3. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H, Minke JM, Rehder J, Richard S, Edlund Toulemonde C, Dinic S, Andreoni C, Audonnet JC, Nordgren R, Juillard V.
    Vet Immunol Immunopathol; 2008 Jun 15; 123(3-4):230-9. PubMed ID: 18372050
    [Abstract] [Full Text] [Related]

  • 4. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
    Kitai Y, Kondo T, Konishi E.
    J Virol Methods; 2011 Jan 15; 171(1):123-8. PubMed ID: 20974180
    [Abstract] [Full Text] [Related]

  • 5. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.
    Liu SA, Haque M, Stanfield B, Andrews FM, Roy AA, Kousoulas KG.
    Vet Microbiol; 2017 Jan 15; 198():51-58. PubMed ID: 28062007
    [Abstract] [Full Text] [Related]

  • 6. Comparison of assays for the detection of West Nile virus antibodies in equine serum after natural infection or vaccination.
    Joó K, Bakonyi T, Szenci O, Sárdi S, Ferenczi E, Barna M, Malik P, Hubalek Z, Fehér O, Kutasi O.
    Vet Immunol Immunopathol; 2017 Jan 15; 183():1-6. PubMed ID: 28063471
    [Abstract] [Full Text] [Related]

  • 7. Immunologic responses to West Nile virus in vaccinated and clinically affected horses.
    Davidson AH, Traub-Dargatz JL, Rodeheaver RM, Ostlund EN, Pedersen DD, Moorhead RG, Stricklin JB, Dewell RD, Roach SD, Long RE, Albers SJ, Callan RJ, Salman MD.
    J Am Vet Med Assoc; 2005 Jan 15; 226(2):240-5. PubMed ID: 15706975
    [Abstract] [Full Text] [Related]

  • 8. West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses.
    Khatibzadeh SM, Gold CB, Keggan AE, Perkins GA, Glaser AL, Dubovi EJ, Wagner B.
    Am J Vet Res; 2015 Jan 15; 76(1):92-100. PubMed ID: 25535666
    [Abstract] [Full Text] [Related]

  • 9. Immunological response in horses following West Nile virus vaccination with inactivated or recombinant vaccine.
    Monaco F, Purpari G, Di Gennaro A, Mira F, Di Marco P, Guercio A, Savini G.
    Vet Ital; 2019 Mar 31; 55(1):73-79. PubMed ID: 30951184
    [Abstract] [Full Text] [Related]

  • 10. Investigation of an outbreak of encephalomyelitis caused by West Nile virus in 136 horses.
    Ward MP, Levy M, Thacker HL, Ash M, Norman SK, Moore GE, Webb PW.
    J Am Vet Med Assoc; 2004 Jul 01; 225(1):84-9. PubMed ID: 15239478
    [Abstract] [Full Text] [Related]

  • 11. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine.
    Davis EG, Zhang Y, Tuttle J, Hankins K, Wilkerson M.
    Vet Immunol Immunopathol; 2008 Dec 15; 126(3-4):293-301. PubMed ID: 18838173
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
    Seino KK, Long MT, Gibbs EP, Bowen RA, Beachboard SE, Humphrey PP, Dixon MA, Bourgeois MA.
    Clin Vaccine Immunol; 2007 Nov 15; 14(11):1465-71. PubMed ID: 17687109
    [Abstract] [Full Text] [Related]

  • 13. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT, Gibbs EP, Mellencamp MW, Bowen RA, Seino KK, Zhang S, Beachboard SE, Humphrey PP.
    Equine Vet J; 2007 Nov 15; 39(6):491-7. PubMed ID: 18065305
    [Abstract] [Full Text] [Related]

  • 14. Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area.
    Fehér O, Bakonyi T, Barna M, Nagy A, Takács M, Szenci O, Joó K, Sárdi S, Korbacska-Kutasi O.
    Vet Immunol Immunopathol; 2020 Sep 15; 227():110087. PubMed ID: 32629300
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L, Bowen R, Karaca K, Murray M, Jagannatha S, Echols B, Nordgren R, Minke JM.
    Vet Ther; 2006 Sep 15; 7(3):249-56. PubMed ID: 17039448
    [Abstract] [Full Text] [Related]

  • 16. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
    Long MT, Gibbs EP, Mellencamp MW, Zhang S, Barnett DC, Seino KK, Beachboard SE, Humphrey PP.
    Equine Vet J; 2007 Nov 15; 39(6):486-90. PubMed ID: 18065304
    [Abstract] [Full Text] [Related]

  • 17. Protection of horses from West Nile virus Lineage 2 challenge following immunization with a whole, inactivated WNV lineage 1 vaccine.
    Bowen RA, Bosco-Lauth A, Syvrud K, Thomas A, Meinert TR, Ludlow DR, Cook C, Salt J, Ons E.
    Vaccine; 2014 Sep 22; 32(42):5455-9. PubMed ID: 25131745
    [Abstract] [Full Text] [Related]

  • 18. Cross-reactivity of Japanese encephalitis virus-vaccinated horse sera in serodiagnosis of West Nile virus.
    Hirota J, Nishi H, Matsuda H, Tsunemitsu H, Shimiz S.
    J Vet Med Sci; 2010 Mar 22; 72(3):369-72. PubMed ID: 19996564
    [Abstract] [Full Text] [Related]

  • 19. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT, Tischer BK, Perkins GA, Wagner B, Goodman LB, Osterrieder N.
    Virus Res; 2007 Apr 22; 125(1):69-78. PubMed ID: 17241683
    [Abstract] [Full Text] [Related]

  • 20. Equine vaccine for West Nile virus.
    Ng T, Hathaway D, Jennings N, Champ D, Chiang YW, Chu HJ.
    Dev Biol (Basel); 2003 Apr 22; 114():221-7. PubMed ID: 14677692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.